CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Paid-in Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2021		58,504,000
Beginning balance at Dec. 31, 2021	$ 1,310,736	$ 5,850	$ 963,851	$ 358,598	$ (10,569)	$ (6,994)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income (loss)	(97,640)			82,580		(180,220)
Stock based compensation expense (in shares)		21,000
Stock based compensation expense	6,620		6,620
Common stock transactions related to stock based employee benefit plans (in shares)		401,000
Common stock transactions related to stock based employee benefit plans	3,031	$ 43	3,958		(970)
Issuance of common stock, pursuant to acquisitions (in shares)		2,550,000
Issuance of common stock, pursuant to acquisitions	90,234	$ 255	89,979
Conversion of options, pursuant to acquisition	3,833		3,833
Dividends on common stock	(29,012)			(29,012)
Increase (decrease) in shares during period (in shares)		2,972,000
Increase (decrease) in stockholders' equity during period	(22,934)	$ 298	104,390	53,568	(970)	(180,220)
Ending balance (in shares) at Sep. 30, 2022		61,476,000
Ending balance at Sep. 30, 2022	1,287,802	$ 6,148	1,068,241	412,166	(11,539)	(187,214)
Beginning balance (in shares) at Jun. 30, 2022		61,410,000
Beginning balance at Jun. 30, 2022	1,329,575	$ 6,141	1,065,167	393,431	(11,632)	(123,532)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income (loss)	(34,445)			29,237		(63,682)
Stock based compensation expense (in shares)		21,000
Stock based compensation expense	2,504		2,504
Common stock transactions related to stock based employee benefit plans (in shares)		45,000
Common stock transactions related to stock based employee benefit plans	670	$ 7	570		93
Dividends on common stock	(10,502)			(10,502)
Increase (decrease) in shares during period (in shares)		66,000
Increase (decrease) in stockholders' equity during period	(41,773)	$ 7	3,074	18,735	93	(63,682)
Ending balance (in shares) at Sep. 30, 2022		61,476,000
Ending balance at Sep. 30, 2022	$ 1,287,802	$ 6,148	1,068,241	412,166	(11,539)	(187,214)
Beginning balance (in shares) at Dec. 31, 2022	71,617,852	71,618,000
Beginning balance at Dec. 31, 2022	$ 1,607,775	$ 7,162	1,377,802	423,863	(13,019)	(188,033)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income (loss)	50,252			74,490		(24,238)
Stock based compensation expense (in shares)		30,000
Stock based compensation expense	10,290		10,290
Common stock transactions related to stock based employee benefit plans (in shares)		713,000
Common stock transactions related to stock based employee benefit plans	4,316	$ 74	5,258		(1,016)
Repurchase of common stock (in shares)		(3,000)
Repurchase of common stock	(45)		(45)
Issuance of common stock, pursuant to acquisitions (in shares)		12,792,000
Issuance of common stock, pursuant to acquisitions	410,738	$ 1,279	409,459
Conversion of options, pursuant to acquisition	10,304		10,304
Dividends on common stock	(45,236)			(45,236)
Increase (decrease) in shares during period (in shares)		13,532,000
Increase (decrease) in stockholders' equity during period	$ 440,619	$ 1,353	435,266	29,254	(1,016)	(24,238)
Ending balance (in shares) at Sep. 30, 2023	85,149,880	85,150,000
Ending balance at Sep. 30, 2023	$ 2,048,394	$ 8,515	1,813,068	453,117	(14,035)	(212,271)
Beginning balance (in shares) at Jun. 30, 2023		85,086,000
Beginning balance at Jun. 30, 2023	2,054,032	$ 8,509	1,809,431	437,087	(14,171)	(186,824)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income (loss)	5,967			31,414		(25,447)
Stock based compensation expense (in shares)		30,000
Stock based compensation expense	3,194		3,194
Common stock transactions related to stock based employee benefit plans (in shares)		34,000
Common stock transactions related to stock based employee benefit plans	585	$ 6	443		136
Dividends on common stock	(15,384)			(15,384)
Increase (decrease) in shares during period (in shares)		64,000
Increase (decrease) in stockholders' equity during period	$ (5,638)	$ 6	3,637	16,030	136	(25,447)
Ending balance (in shares) at Sep. 30, 2023	85,149,880	85,150,000
Ending balance at Sep. 30, 2023	$ 2,048,394	$ 8,515	$ 1,813,068	$ 453,117	$ (14,035)	$ (212,271)